Soon Khai Low, Yu Fujiwara, Daisuke Nishizaki, Taylor J. Jensen, R.J. Seager, Paul DePietro, Shumei Kato, Razelle Kurzrock. "High expression of CIITA, the master MHC-II regulator, as a predictor of survival benefit from immune checkpoint inhibitors across solid tumors.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e14589